NF2 and lung adenocarcinoma: The genes whose loss is predicted to be detrimental to EGFR-driven tumors (i.e., Keap1, Lkb1, and Nf2) are rarely co-mutated with EGFR in human lung adenocarcinoma as predicted (Fig. 6B).